| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8707111 | Oral Oncology | 2018 | 11 Pages |
Abstract
These findings indicate that immunohistochemical assessment of CD1 overexpression may be useful as a prognostic biomarker for OSCC.
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
Pablo Ramos-GarcÃa, Miguel Ángel González-Moles, LucÃa González-Ruiz, Isabel Ruiz-Ávila, Ángela Ayén, José Antonio Gil-Montoya,